Skip to content
Butterfly child being treated at the EB House Austria

Current Clinical trials in the EB House

The Study Centre in the EB House Austria is currently conducting several clinical trials.

Information on the ongoing trials can be found in the table below.

Due to the current Covid-19 pandemic some studies are on-hold. We will update this table regularly to keep you informed.

  Rigosertib Nivosquacs (Dermatologie)
Application form oral capsules / infusion infusion
Placebo-group    

EBS

 
JEB  
DEB
Kindler  
Applicable age 18-79 years from 18 years
Special inclusion criteria  
  • unresectable, locally advanced or metastatic squamous cell carcinoma
  • certain lab values within given ranges
 
 
  • locally advanced or metastatic squamous cell carcinoma (stage III/IV)
  • certain lab values within given ranges
  • no previous therapies with PD-1 or CTLA-4 antibodies
 
Site visits 17-20 (interval 1-4 weeks, plus weekly telephone calls) every 2 weeks (for max. 2 years)

 

If you have any questions about individual studies or trials, please contact the study coordinator:

Kontakt

Sophie Kitzmüller, PhD

Study Coordinator
Back to main navigation